The primary aim for this study therefore is:1. To study the effects of an 8-week exercise training on RNA expression profiles in adipose tissue and skeletal muscle in obese individualsSecondarily we also aim:2. To relate changes in RNA expression…
ID
Source
Brief title
Condition
- Endocrine and glandular disorders NEC
- Vascular hypertensive disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- RNA expression levels in subcutaneous adipose tissue (i.e. fat biopsy and
subsequent transcriptome analysis)
- RNA expression levels in skeletal muscle (i.e. muscle biopsy and subsequent
transcriptome analysis)
Secondary outcome
- Insulin sensitivity (hyperinsulemic, euglycemic clamp)
- Levels of adipokines and cytokines and levels of macrophage infiltration in
subcutaneous adipose tissue
- Levels of cytokines and myokines in skeletal muscle
- Circulating inflammatory markers, adipokines and myokines (venous blood
sampling)
- Cardiovascular risk markers (venous blood sampling)
- Brachial artery endothelial function (non-invasive vascular echography)
- Carotid artery intima-media thickness (non-invasive vascular echography)
Background summary
Presence of low-grade chronic inflammatory is suggested to be a key factor in
the development of the metabolic syndrome in subjects with obesity.1, 2 By
secreting pro-inflammatory cytokines and adipokines, adipose tissue exerts
paracrine and endocrine effects in multiple target tissues, such as skeletal
muscle and the liver. This has direct effects on glucose homeostasis and plays
a key role in the development of insulin resistance and cardiovascular
disease.2, 3
Exercise training has been proven to be a powerful lifestyle intervention to
improve insulin sensitivity and other components of the metabolic syndrome and
cardiovascular risk factors.4 Benefits of exercise training cannot be simply
explained by changes in body weight. To explain improvements in metabolic
function and cardiovascular risk factors after exercise training, analysis of
molecular changes in these tissues is paramount.5 Whilst most previous studies
focused on skeletal muscle, relatively little is known about potential
molecular changes in adipose tissue in response to an exercise training.5-7
Therefore, the first aim is to study effects of 8-week exercise training on RNA
expression profiles in adipose tissue and skeletal muscle in obese subjects,
and subsequently relate these changes to exercise-induced improvement in
insulin sensitivity and cardiovascular function.
Study objective
The primary aim for this study therefore is:
1. To study the effects of an 8-week exercise training on RNA expression
profiles in adipose tissue and skeletal muscle in obese individuals
Secondarily we also aim:
2. To relate changes in RNA expression profiles in adipose tissue and skeletal
muscle in to adaptations in metabolic and cardiovascular function in response
to exercise training.
Study design
Single-center intervention study
Intervention
8-week exercise training intervention
Study burden and risks
Performance of a subcutaneous fat or muscle biopsy is not associated with an
important health risk.8 Complications include infection, bleeding and hematoma
formation (<2%), whilst these complications will resolve within 2 weeks. The
biopsy procedures do not induce discomfort and/or functional impairment. After
the muscle biopsy, subjects are not allowed to perform exercise during 12 hours
and will be instructed not to take a bath for 48 hours. During the
hyperinsulemic, euglycemic clamp, two venous catheters are placed in veins of
arms of the subjects. Venous catheterization can induce a hematoma (<5%).
However, this is completely reversible within 2 weeks and will not induce
permanent damage. Taken together, the nature and extent of burden and risks
associated with the different measurements are modest
Philips van Leijdenlaan 15
Nijmegen 6500HB
NL
Philips van Leijdenlaan 15
Nijmegen 6500HB
NL
Listed location countries
Age
Inclusion criteria
- age 18 years of older
- body mass index > 28 kg/m2
Exclusion criteria
- Use of medication interfering with fat metabolism (thiazolidinediones)
- Type 1 or 2 diabetes mellitus
- Smoking
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL50995.091.14 |
OMON | NL-OMON25990 |